Design, synthesis, and biological evaluation of novel triazoloquinazolinone derivatives as SHP2 protein inhibitors
A novel series of triazoloquinazolinone derivatives were designed, synthesised, and evaluated for their in vitro biological activities against the SHP2 protein. Moreover, some compounds were evaluated against A375 cells. The results revealed that target compounds possessed moderate to excellent inhi...
Guardado en:
Autores principales: | Rongshuang Luo, Zhongyuan Wang, Dali Luo, Yumei Qin, Chunshen Zhao, Di Yang, Tian Lu, Zhixu Zhou, Zhuyan Huang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f6b4e6f2b10c48e0b8e1d41569278350 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors
por: Xiaozheng Xu, et al.
Publicado: (2021) -
Thyroid cancer MR molecular imaging via SHP2-targeted nanoparticles
por: Hu Z, et al.
Publicado: (2019) -
Discriminating between competing models for the allosteric regulation of oncogenic phosphatase SHP2 by characterizing its active state
por: Paolo Calligari, et al.
Publicado: (2021) -
Biological evaluation of novel 6-Arylbenzimidazo [1,2-c] quinazoline derivatives as inhibitors of LPS-induced TNF- alpha secretion
por: GALARCE,GLORIA D, et al.
Publicado: (2008) -
The abnormal activation of D1R/Shp-2 complex involved in levodopa-induced dyskinesia in 6-hydroxydopamine-lesioned Parkinson’s rats
por: Wu N, et al.
Publicado: (2018)